Preventing kidney stones has 1 intervention with far stronger evidence than any supplement, and it costs nothing. Pooled data give high fluid intake a relative risk of 0.40. This article...
Read More
Chanca piedra is marketed for gallstones and liver health as often as for kidney stones. Those 2 claims have almost 0 human evidence behind them. This article explains why kidney...
Read More
The 150-patient chanca piedra trial recorded no side effects at all over its 180 days of follow-up. That is a genuinely good safety signal for a 3-month course. The cautions...
Read More
The studied dose of chanca piedra is 2 g daily, taken for at least 3 months. That is 2 capsules of 1000 mg, and it is the only figure with...
Read More
The main chanca piedra trial enrolled 150 patients after lithotripsy. Its headline number is quoted everywhere without the p value of 0.48 that goes with it. This article reads that...
Read More
Chanca piedra has 4 commonly claimed benefits, and 1 of them rests on 2 human studies while the other 3 rest on tradition. That ratio is the story. This article...
Read More
Chanca piedra is 1 small tropical herb whose name translates as stone breaker, and it is sold almost entirely for kidney stones. Only 2 human trials sit behind that reputation....
Read More
Cat's claw is sold for immunity, gut health and parasites, and those 3 claims have very different amounts of evidence behind them. Two of the 3 have none in humans....
Read More
Cat's claw comes as capsules, tincture, tea and purified extract, and the choice is about practicality rather than potency. Only 2 of those 4 are everyday options. This article compares...
Read More
Cat's claw doses run from 1000 mg of bark to a few drops of tincture, and the 2 numbers are not comparable. The trials used specific preparations rather than either....
Read More
Cat's claw was well tolerated in both joint trials, with only minor side effects across 52 weeks in 40 rheumatoid arthritis patients. Its real cautions are about immunity, not toxicity....
Read More
Cat's claw has 2 randomized joint trials, 1 in knee osteoarthritis and 1 in rheumatoid arthritis. Together they cover 85 patients, which is small but real. This article sets out...
Read More